Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis

Clin Exp Rheumatol. 2019 Nov-Dec;37(6):1096. Epub 2019 Jun 28.

Authors

Federica Macaluso¹, Giuliana Guggino¹, Daniele Mauro¹, Chiara Rizzo¹, Rodolfo Bignone¹, Francesco Ciccia²

Affiliations

¹ University of Palermo, Italy.
² University della Campania L. Vanvitelli, Naples, Italy. [email protected].

PMID: 31287406

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Antibodies, Monoclonal, Humanized / therapeutic use*
Humans
Multiple Sclerosis* / drug therapy
Patients
Safety
Spondylitis, Ankylosing* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
secukinumab